Qatar Biomedical Research Institute to Set Up Joint Research Laboratories and Programmes with Leading Japanese Institute Riken

Collaboration Aimed At Advancing Preventive And Personalised Medicine In Hospitals In Both Countries

Qatar Foundation Research & Development’s (QF R&D) Qatar Biomedical Research Institute (QBRI), and the Japanese Preventive Medicine & Diagnosis Innovation Program at RIKEN (RIKEN-PMI), have announced plans to establish joint research laboratories and programmes in Qatar and Japan, aimed at advancing preventive and personalised medicine in Qatar.

At a recent meeting in Doha, QBRI signed a letter of intent with RIKEN, one of the world’s leading scientific innovators and Japan’s largest cutting-edge research institution. The agreement will establish joint programmes to carry out projects with academic researchers and hospitals in both countries.

Through this latest initiative, QBRI is contributing to Qatar Foundation’s mission to build Qatar’s innovation and technology capacity by improving and transforming healthcare through research in prevention, diagnosis and treatment of diseases affecting Qatar and the region.

Earlier this year, Her Highness Sheikha Mozah bint Nasser, Chairperson of Qatar Foundation, accompanied by a delegation from Qatar Foundation’s Research and Development (QF R&D) – one of the main QF pillars – visited a number of research centres in Japan with the goal of increasing research and development collaboration between the two countries.

During the visit, Qatar Foundation and RIKEN signed a Memorandum of Understanding to establish a framework enabling the parties to expand scientific exchange in the fields of computing, energy, environment and biomedical research.

The QBRI press release is available to download here and Riken publicity can be found here.